Published in J Med Screen on January 01, 2012
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Modern mammography screening and breast cancer mortality: population study. BMJ (2014) 1.92
Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program. Cancer (2013) 1.25
Breast cancer in European Union: an update of screening programmes as of March 2014 (review). Int J Oncol (2014) 0.88
Screening mammography & breast cancer mortality: meta-analysis of quasi-experimental studies. PLoS One (2014) 0.87
Association of symptoms and breast cancer in population-based mammography screening in Finland. Int J Cancer (2014) 0.82
Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study. Br J Cancer (2016) 0.81
Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme. PLoS One (2014) 0.79
EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer. Oncotarget (2016) 0.77
Breast carcinoma detection modes and death in a female population in relation to population-based mammography screening. Springerplus (2014) 0.75
Increased breast cancer screening and downstaging in Colombian women: A randomized trial of opportunistic breast-screening. Int J Cancer (2015) 0.75
Quantra™ should be considered a tool for two-grade scale mammographic breast density classification. Br J Radiol (2016) 0.75
Design and respondent selection of a population-based study on associations between breast cancer screening, lifestyle and quality of life. BMC Public Health (2015) 0.75
Cancer mortality in former East and West Germany: a story of unification? BMC Cancer (2017) 0.75
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol (2010) 7.29
End-of-life decision-making in six European countries: descriptive study. Lancet (2003) 5.16
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol (2009) 4.99
Breast cancer mortality in Norway after the introduction of mammography screening. Int J Cancer (2012) 3.47
Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ (2005) 3.21
Rural Tanzanian women's awareness of danger signs of obstetric complications. BMC Pregnancy Childbirth (2009) 2.70
The Gothenburg Breast Screening Trial. Cancer (2003) 2.59
Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol (2006) 2.59
Occupation and cancer - follow-up of 15 million people in five Nordic countries. Acta Oncol (2009) 2.59
The influence of active and passive smoking on habitual snoring. Am J Respir Crit Care Med (2004) 2.43
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst (2008) 2.36
Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol (2013) 2.32
Incidence of uveal melanoma in Europe. Ophthalmology (2007) 2.30
Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J (2006) 2.24
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial. Lancet Oncol (2008) 2.24
Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen (2012) 2.21
Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst (2006) 2.16
Position paper: breast cancer screening, diagnosis, and treatment in Denmark. Acta Oncol (2014) 2.04
[Arguments against the distinction between primary and secondary prevention and prevention and treatment]. Epidemiol Prev (2003) 2.02
Predicting the risk of a false-positive test for women following a mammography screening programme. J Med Screen (2007) 1.83
Incidence of cervical cancer after several negative smear results by age 50: prospective observational study. BMJ (2009) 1.81
Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res (2006) 1.79
High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol (2012) 1.78
Research recommendations for selected IARC-classified agents. Environ Health Perspect (2010) 1.73
Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review. BMJ (2011) 1.72
The incidence of diabetes among 0-34 year olds in Sweden: new data and better methods. Diabetologia (2014) 1.72
Women's death in Scandinavia--what makes Denmark different? Eur J Epidemiol (2004) 1.69
Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study. BJU Int (2004) 1.68
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer (2008) 1.68
Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study. Eur J Gastroenterol Hepatol (2007) 1.65
Incidence of prostate cancer after termination of screening in a population-based randomised screening trial. Eur Urol (2013) 1.64
Determinants of participation in colorectal cancer screening with faecal occult blood testing. J Public Health (Oxf) (2009) 1.62
Occupation and bladder cancer among men in Western Europe. Cancer Causes Control (2003) 1.54
The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen (2012) 1.46
A pooled analysis of interval cancer rates in six European countries. Eur J Cancer Prev (2010) 1.46
The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J Med Screen (2012) 1.45
Quality of antenatal care in rural Tanzania: counselling on pregnancy danger signs. BMC Pregnancy Childbirth (2010) 1.44
Breast cancer in limited-resource countries: early detection and access to care. Breast J (2006) 1.43
Breast carcinoma survival in Europe and the United States. Cancer (2004) 1.43
Has cytology become obsolete as a primary test in screening for cervical cancer? J Med Screen (2010) 1.42
Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer (2005) 1.40
[Overdiagnosis and overtreatment of breast cancer]. Ugeskr Laeger (2008) 1.40
[Degree of coverage of Danish health sciences research in the Science Citation Index, 1998]. Ugeskr Laeger (2004) 1.39
Continuous deep sedation: physicians' experiences in six European countries. J Pain Symptom Manage (2006) 1.39
[End-of-life care and end-of-life medical decisions: the ITAELD study]. Epidemiol Prev (2011) 1.39
[Mammography screening without overdiagnosis]. Ugeskr Laeger (2004) 1.38
[Suicide mortality among cancer patients]. Epidemiol Prev (2012) 1.38
Breast cancer incidence after the introduction of mammography screening: what should be expected? Cancer (2006) 1.35
Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res (2009) 1.35
A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial. Eur J Cancer (2011) 1.34
Determinants of successful implementation of population-based cancer screening programmes. Eur J Cancer (2011) 1.33
Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries. Occup Environ Med (2014) 1.33
Estimating the benefits of mammography screening: the impact of study design. Epidemiology (2007) 1.32
Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control (2003) 1.32
Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe. Int J Cancer (2004) 1.31
A high positive predictive value algorithm using hospital administrative data identified incident cancer cases. J Clin Epidemiol (2007) 1.30
Fertility pattern does not explain social gradient in breast cancer in denmark. Int J Cancer (2004) 1.30
Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial. Lancet Oncol (2012) 1.29
Mammography screening in the county of Fyn. November 1993-December 1999. APMIS Suppl (2003) 1.27
The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care (2003) 1.25
Mammography screening in Denmark. Dan Med Bull (2011) 1.22
Incidence of type 1 diabetes in Sweden among individuals aged 0-34 years, 1983-2007: an analysis of time trends. Diabetes Care (2011) 1.22
E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut (2010) 1.22
An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer (2009) 1.22
Overdiagnosis in screening mammography in Denmark: population based cohort study. BMJ (2013) 1.20
Balancing harms and benefits of service mammography screening programs: a cohort study. Breast Cancer Res (2012) 1.19
Socioeconomic status and breast cancer in Denmark. Int J Epidemiol (2003) 1.19
Non-participation in screening: the case of cervical cancer in Denmark. Prev Med (2012) 1.17
Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen (2012) 1.16
Effectiveness of maternal referral system in a rural setting: a case study from Rufiji district, Tanzania. BMC Health Serv Res (2010) 1.15
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. Eur J Cancer (2007) 1.15
Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer (2005) 1.15
The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomarkers Prev (2007) 1.15
Physicians' attitudes towards end-of-life decisions: a comparison between seven countries. Soc Sci Med (2004) 1.13
Lead-time in the European Randomised Study of Screening for Prostate Cancer. Eur J Cancer (2010) 1.13
[Cancer incidence estimation by hospital discharge flow as compared with cancer registries data]. Epidemiol Prev (2010) 1.12
Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres. J Med Screen (2005) 1.12
Overdiagnosis in breast cancer: design and methods of estimation in observational studies. Prev Med (2011) 1.12
False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen (2012) 1.11
Performance of clinical mammography: a nationwide study from Denmark. Int J Cancer (2006) 1.11
Survival in patients with uveal melanoma in Europe. Arch Ophthalmol (2008) 1.11
Women's patterns of participation in mammography screening in Denmark. Eur J Epidemiol (2006) 1.11
Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study. Diabetes (2010) 1.11
Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol (2002) 1.10
Is 20% of a loaf enough? Cancer (2013) 1.09
Lead time and down-staging in the survival of cervical cancer cases detected by screening. Prev Med (2013) 1.09
Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark. Cancer Epidemiol (2011) 1.09
Standardization of Gleason grading among 337 European pathologists. Histopathology (2013) 1.09
Prevalence and correlates of pulmonary emphysema in smokers and former smokers. A densitometric study of participants in the ITALUNG trial. Eur Radiol (2008) 1.09
IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5. Genes Immun (2007) 1.09
Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care (2003) 1.08